AGC Biologics

Highly Engaged Employees

Founded in 2007, AGC Biologics is a prominent player in the biotechnology and pharmaceutical sectors, specializing in the development and manufacturing of protein-based therapeutics. The company provides comprehensive end-to-end solutions, supporting clients from pre-clinical stages through to full-scale commercial production. By leveraging advanced mammalian and microbial production systems, AGC Biologics addresses complex biopharmaceutical manufacturing challenges with precision and technical rigor. Their commitment to quality management systems ensures that every therapeutic product meets stringent global regulatory standards, facilitating seamless transitions from development to market.

Operating with a robust workforce of 1,000-5,000 employees, the organization maintains a significant global footprint across 6 strategic locations. This operational scale allows for high-capacity manufacturing and specialized process development, including cell therapy, vector production, and stem cell technologies. Meet AGC Biologics's team to learn about the leadership and technical experts driving these complex operations. The company’s infrastructure is designed to handle diverse biopharmaceutical requirements, ranging from clinical batch production to large-scale commercial manufacturing, ensuring consistent delivery and customer satisfaction across their international client base.

AGC Biologics competes in a highly specialized market against firms like KBI Biopharma, FUJIFILM Biotechnologies, and Celltrion. Their service portfolio includes contract development, biopharmaceutical manufacturing, and customized formulation services. By integrating deep industry expertise with state-of-the-art chromatography and DNA analysis techniques, they maintain a competitive edge in the biopharmaceutical contract development space. The company continues to expand its capabilities in cell and gene therapy, reinforcing its position as a reliable partner for organizations seeking high-quality, scalable, and compliant biopharmaceutical manufacturing solutions in an increasinglyView more...